Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling-Final
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 12, 2017
September 30, 2021
fa68136f-ad70-49ea-a8cd-cc47e646f4a1
Related Documents
Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer (DTC) Promotional Labeling and Advertisements
Guidance DocumentDecember 12, 2023Center for Drug Evaluation and Research
Nonproprietary Naming of Biological Products Guidance for Industry
Guidance DocumentJanuary 12, 2017Center for Drug Evaluation and Research
Individual Patient Expanded Access Applications: Form FDA 3926
Guidance DocumentOctober 3, 2017Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox